Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rich

Showing results (401-410 of 558) with videos related to

Pageof 56
Sort By:
Cell Stem Cell|November 4, 2017
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic EfficacyWenchao Zhou, Cong Chen, Yu Shi, et al.
Science Signaling|May 7, 2015
Feedback circuitry between miR-218 repression and RTK activation in glioblastomaLijoy K Mathew, Peiwei Huangyang, Vera Mucaj, et al.
Science Translational Medicine|September 11, 2015
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastomaMonica Venere, Craig Horbinski, James F Crish, et al.
Molecular Cell|February 19, 2022
A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Journal of Neuro-Oncology|March 13, 2012
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant gliomaDavid A Reardon, James J Vredenburgh, Annick Desjardins, et al.
Molecular Cell|June 1, 2024
Retraction Notice to: A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Plos One|January 12, 2013
Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesKumar Sukhdeo, Rosanto I Paramban, Jason G Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomasAnnick Desjardins, David A Reardon, James E Herndon, et al.
Oncotarget|June 9, 2016
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cellsMonica E Burgett, Justin D Lathia, Patrick Roth, et al.
Cancer Research|March 8, 2012
Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastomaPing Huang, M R Sandhya Rani, Manmeet S Ahluwalia, et al.
Pageof 56

Showing results (401-410 of 558) with videos related to

Sort By:
Pageof 56
Cell Stem Cell|November 4, 2017
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic EfficacyWenchao Zhou, Cong Chen, Yu Shi, et al.
Science Signaling|May 7, 2015
Feedback circuitry between miR-218 repression and RTK activation in glioblastomaLijoy K Mathew, Peiwei Huangyang, Vera Mucaj, et al.
Science Translational Medicine|September 11, 2015
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastomaMonica Venere, Craig Horbinski, James F Crish, et al.
Molecular Cell|February 19, 2022
A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Journal of Neuro-Oncology|March 13, 2012
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant gliomaDavid A Reardon, James J Vredenburgh, Annick Desjardins, et al.
Molecular Cell|June 1, 2024
Retraction Notice to: A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Plos One|January 12, 2013
Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesKumar Sukhdeo, Rosanto I Paramban, Jason G Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomasAnnick Desjardins, David A Reardon, James E Herndon, et al.
Oncotarget|June 9, 2016
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cellsMonica E Burgett, Justin D Lathia, Patrick Roth, et al.
Cancer Research|March 8, 2012
Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastomaPing Huang, M R Sandhya Rani, Manmeet S Ahluwalia, et al.
Pageof 56